Hasil Pencarian :: Kembali

Ditemukan 9174 dokumen yang sesuai dengan query ::  Simpan CSV
cover
Health Policy and Planning (HPP), Vol. 28, No.1, Jan. 2013: hal. 62-74
[s.l.] : [s.n.] : s.a.]
Indeks Artikel Jurnal-Majalah   Pusat Informasi Kesehatan Masyarakat
cover
Yaslis Ilyas, Hasbullah Thabrany, Bagus Satriya Budi, Pujiyanto, Hendratno
LP 362.1 COS c
Depok : FKM UI, 2003
Laporan Penelitian   Pusat Informasi Kesehatan Masyarakat
cover
Alastair M. Gray, Philip M. Clrke, Janel Wolstenholme, Sarah Wordsworth
362.1 APP a
[s.l.] : Oxford University Press, 2011
Buku (pinjaman 1 minggu)   Pusat Informasi Kesehatan Masyarakat
cover
Workshop on evidence for health policy: burden of disease, Cost-Effectiveness, and health systems (Daftar isi: 1.Expanding the WHO tuberculosis control strategy: rethinking the role active case-finding, C.J.L. Murray; 2. Modeling the impact of global tuberculosis control strategies, ChristopherJ.L. Murray; 3. The decision rules of cost-effectiveness analysis, Goran Karlsson; 4. On the decision relus of cost-effectiveness analysis, Magnus Johannesson; 5. Cost-effectiveness and capital costs, Goran k; 6. How attractive does a new technology have to be to warrant adoption and utilization? tentative guidelines for using clinical and economic evaluations, Andreas Laupacis; 7. Methods for the economic evaluation of health care programmes, Michael F. Drummond; 8. Cost-effectiveness and cost-benefit analysis of health services: the methodology and its application, A. Griffiths; 9. Valuing health care: costs, benefits, and effectiveness of pharmaceuticals and other medical technologies, Frank A. Sloan; 10. Cost-benefit analysis (CBA); 11. Use of contingent valuation to place a monetary value on pharmacy services: an overview and review of the literature, Karen B; 12. The use of conjoint analysis to elicit willingness-to-pay values: proceed with caution?, Julie Ratcliffe; 13. Is there a role for benefit-cost analysis in environmental, health, and safety regulation ?, Kenneth J. Arrow; 14. Reasons and persons, Derek Parfit; 15. Qalys and ethics: a health economist's perspective, Alan Williams; 16. Double jeopardy and the use of QALYs in health care allocation, Peter Singer; 17. Double jeopardy, the equal value of lives and the veil of ignorance: a rejoinder to harris, John McKie; 18. The value of DALY life: problems with ethics and validity of disability adjusted life years, Erik Nord; 19. Public preferences for the allocation of donor liver grafts for transplantation, Julie Ratclife; 20. Distributing scarce livers: the moral reasoning of the general public, Peter A. Ubel; 21. Recognizing bedside rationing: clear cases and tough calls, Peter A. Ubel; 22. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial, Mohammad A. Chaudhary; 23. Reflecting uncertainty in cost-effectiveness analysis, W.G. Manning; 24. Hanling uncertanty in economic evaluation, Andrew Briggs; 25. Probabilistic sensitivity analysis in cost-effectiveness: an application from a study of vaccination against pneumococcal bacteremia in the elderly, William Whang; 26. Estimating uncertainty ranges for cost by the bootstrap procedure combined with probabilistic sensitivity analysis, Joanne Lord; 27. Uncertaintyin the economic evaluation of health care technologies: the role of sensitivity analysis, Andrew Briggs; 28. Building uncertainty into cost-effectiveness rankings portofolio risk-return tradeoffs and implications for decision rules, Bernie J. O'Brien; 29. Cost-effectiveness of chemotherapy for sputum smear-positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania, Eric De Jonghe; 30. Linking measures of health gain to explicit priority setting by an area health service in Australia, David A Cromwell; 31. Using discrete choice modelling in priority setting: an application to clinical service developments, Shelley Farrar; 32. Cost-effectiveness analysis and policy choices: investing in health systems, C.J.L. Murray; 33. A cost-effectiveness model for allocating health sector resources, Christopher Murray; 34. Disease control priorities in developing countries: an overview, Dean T. Jamison; 35. Oregon's medicaid ranking and cost-effectiveness: is there any relationship ?, Tammy O. Tengs; 36. Five-hundred life-saving interventions and their cost-effectiveness, Tammy O. Tengs; 37. Prioritising health services in an era of limits: the Oregon experience, John A Kitzhaber; 38. Priority setting: lessons from Oregon, Jennifer Dixon; 39. Oregon's methods: did cost-effectiveness analysis fail?; 40.
P 362.1 WOR w
[s.l.] : Geneva: WHO, 2000, s.a.]
Prosiding   Pusat Informasi Kesehatan Masyarakat
cover
T. Tan Torres Edejer, R. Baltussen
658.155 MAK
Geneva : WHO, 2003
Buku (pinjaman 1 minggu)   Pusat Informasi Kesehatan Masyarakat
cover
cover
338.433621 COS
[s.l.] : [s.n.] : s.a.]
Buku (pinjaman 1 minggu)   Pusat Informasi Kesehatan Masyarakat
cover
338.433621 COS
[s.l.] : [s.n.] : s.a.]
Buku (pinjaman 1 minggu)   Pusat Informasi Kesehatan Masyarakat
cover
edited by Marthe Siegel ... [et.al.]
338.4 COS
New York : Oxford University Press, 1996
Buku (pinjaman 1 minggu)   Pusat Informasi Kesehatan Masyarakat
cover
Workshop on evidence for health policy: burden of disease, cost-effectiveness, and health systems. (Daftar isi: 1. Compositional models for mortality by age, sex and cause, Joshua A Salomon; 2. The epidemiological transitional: policy and planning implications for developing countries, James N. Gribble; 3. Methodology for measuring health-state preferences - 1: measurement strategies, Debra G. Froberg; 4. Methodology for measuring health-State preferences - II: scaling methods, Debra G. Froberg; 5. Methodology for measuring health-State preferences - III: population and context effects, Debra G. Froberg; 5. Measurement of health state utilities for economic appraisal : a review, George W. Torrance; 7. Methods for quality adjusment of life years, Erik Nord; 8. The person-trade-off approach to valuing health care programs, Erik Nord; 9. Cost utility analysis: what should be measured?, J. Richardson; 10. Health state valuations from the general public using the visual analogue scale, C Gudex; 11. Modeling valuations for EuroQol health states, Paul Dolan; 12. Deriving preference-based single index from the UK SF-36 health survey, John Brazier; 13. Measuring preferences for health states worse than death, Donald L. Patrick; 14. Multiattribute utility function for a comprehensive health status classification system health utilities index mark 2, George W. Torrance; 15. Evaluating healthy days of life gained from health projects, Howard Barnum; 16. The utility of health at different stages in life: a quantitative approach, Jan J. V.B; 17. The economic cost of illness revisited, Barbara S. Cooper; 18. Is the valuation of a qaly gained independent of age? some empirical evidence, Magnus J; 19. Discounting in the economic evaluation of health care interventions, Murray K; 20. Maximizing health benefits vs egalitarianism: an Australian survey of health issues, Erik N; 21. Estimating the cost of illness, Dorothy P.R.; 22. Discounting in health care decision-making: time for a change ?, Trevor A. Sheldon; 23. Discounting the future: influence of the economic model, Robert R. West; 24. Penn world tables 5.6, Alan H; 25. On the comparable quantification of health risks: lessons from the global burden of disease study, Christophr J.L.M; 26. Conceptual problems in the definition and interprtation of attributable fractions, Sander G; 27. Estimability and estimation of excess and etiologic fractions, James M. Robin; 28. Reducing the global burden of blood pressure-related cardiovascular disease, Anthony R; 29. The Australian burden of disease study: measuring the loss of health from diseses, injuries and risk factors, Colin DM; 30. Mortality in relation to smoking: 40 years' observations on male British doctors, Richard D; 31. Estimated numbers of deaths from coronary heart disease "Caused" and "prevented" by alcohol: an example from Finland, Pia M; 32. Mortality from tobacco in developed countries: indirect estimation from national vital statistics, Richard P.A; 33. Intake of fatty acids and risk of coronary heart disease in a cohort of finnish men, Pirjo Pietinen; 34. Alcohol consumption and mortality among middle-aged and elderly U.S. adults, Michael J. Thun; 35. An improved aetiologic fraction of alcohol caused morbidity and mortality; 36. Dietary fat intake and the risk of coronary heart disease in women, Frank B. Hu; 37. Obesity, mortality and cardiovascular disease in the munster heart study (PROCAM), Helmut S; 38. The burden of dsease in Mexico in 1994: advances and challenges, Rafael Lozano; 39. The burden of disease and injury in Australia, Colin Mathers)
P 362.1 WOR w
[s.l.] : Geneva: WHO, 2000, s.a.]
Prosiding   Pusat Informasi Kesehatan Masyarakat
:: Pengguna : Pusat Informasi Kesehatan Masyarakat
Library Automation and Digital Archive